Literature DB >> 17381305

Structural studies of the purine and SAM binding riboswitches.

S D Gilbert1, R K Montange, C D Stoddard, R T Batey.   

Abstract

Riboswitches are recently discovered genetic regulatory elements found in the 5'-untranslated regions of bacterial mRNAs that act through their ability to specifically bind small-molecule metabolites. Binding of the ligand to the aptamer domain of the riboswitch is communicated to a second domain, the expression platform, which directs transcription or translation of the mRNA. To understand this process on a molecular level, structures of three of these riboswitches bound to their cognate ligands have been solved by X-ray crystallography: the purine, thiamine pyrophosphate (TPP), and S-adenosylmethionine (SAM-I) binding aptamer domains. These studies have uncovered three common themes between the otherwise different molecules. First, the natural RNA aptamers recognize directly or indirectly almost every feature of their ligand to achieve extraordinary specificity. Second, all of these RNAs use a complex tertiary architecture to establish the binding pocket. Finally, in each case, ligand binding serves to stabilize a helix that communicates the binding event to the expression platform. Here, we discuss these properties of riboswitches in the context of the purine and SAM-I riboswitches.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17381305     DOI: 10.1101/sqb.2006.71.015

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  18 in total

Review 1.  Recognition of S-adenosylmethionine by riboswitches.

Authors:  Robert T Batey
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-01-12       Impact factor: 9.957

2.  Non-nearest-neighbor dependence of the stability for RNA bulge loops based on the complete set of group I single-nucleotide bulge loops.

Authors:  Joshua M Blose; Michelle L Manni; Kelly A Klapec; Yukiko Stranger-Jones; Allison C Zyra; Vasiliy Sim; Chad A Griffith; Jason D Long; Martin J Serra
Journal:  Biochemistry       Date:  2007-11-30       Impact factor: 3.162

3.  A general strategy to solve the phase problem in RNA crystallography.

Authors:  Amanda Y Keel; Robert P Rambo; Robert T Batey; Jeffrey S Kieft
Journal:  Structure       Date:  2007-07       Impact factor: 5.006

Review 4.  Structural features of metabolite-sensing riboswitches.

Authors:  Catherine A Wakeman; Wade C Winkler; Charles E Dann
Journal:  Trends Biochem Sci       Date:  2007-08-30       Impact factor: 13.807

5.  Determining structures of RNA aptamers and riboswitches by X-ray crystallography.

Authors:  Andrea L Edwards; Andrew D Garst; Robert T Batey
Journal:  Methods Mol Biol       Date:  2009

6.  Modularity of select riboswitch expression platforms enables facile engineering of novel genetic regulatory devices.

Authors:  Pablo Ceres; Andrew D Garst; Joan G Marcano-Velázquez; Robert T Batey
Journal:  ACS Synth Biol       Date:  2013-03-28       Impact factor: 5.110

7.  Label-free microfluidic characterization of temperature-dependent biomolecular interactions.

Authors:  Thaihuu Nguyen; Renjun Pei; Donald W Landry; Milan N Stojanovic; Qiao Lin
Journal:  Biomicrofluidics       Date:  2011-08-17       Impact factor: 2.800

Review 8.  Phosphoribosyl Diphosphate (PRPP): Biosynthesis, Enzymology, Utilization, and Metabolic Significance.

Authors:  Bjarne Hove-Jensen; Kasper R Andersen; Mogens Kilstrup; Jan Martinussen; Robert L Switzer; Martin Willemoës
Journal:  Microbiol Mol Biol Rev       Date:  2016-12-28       Impact factor: 11.056

9.  Discrimination between closely related cellular metabolites by the SAM-I riboswitch.

Authors:  Rebecca K Montange; Estefanía Mondragón; Daria van Tyne; Andrew D Garst; Pablo Ceres; Robert T Batey
Journal:  J Mol Biol       Date:  2009-12-16       Impact factor: 5.469

10.  Mutational analysis of the purine riboswitch aptamer domain.

Authors:  Sunny D Gilbert; Crystal E Love; Andrea L Edwards; Robert T Batey
Journal:  Biochemistry       Date:  2007-10-26       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.